This Week in 340B: June 30 – July 6, 2026
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to…
Read the full articleYou might also wanna read
From Constitutional Attack to Statutory Combat: The Next Wave of Medicare Drug-Price Litigation
By: Jimmie L. Bullock Background On May 18, 2026, the Supreme Court declined to review six pharmaceutical manufacturers’ challenges to the M
Filing Litigation to Challenge FDA Delays in NDA or BLA Review
STAT+: Medicare takes another swing at 340B cuts to hospitals
Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.
Weekly Update for Government Contractors and Commercial Businesses – July 9, 2026
The Weekly Update recaps recent legislative and regulatory updates affecting government contractors and commercial businesses. If you have q
Access to Mifepristone Across the United States: An Issue of State Abortion Access or Federal Drug Regulation?
Written by: Jessie Litwin On May 1, 2026, the Fifth Circuit Court of Appeals issued a decision—after the state of Louisiana challenged the F
The Chemical Compound — Quarter 1 2026
This edition of our quarterly newsletter on chemical regulatory developments provides updates on litigation, regulatory, legislative, and po
Comments
Sign in to join the conversation.
No comments yet. Be the first.